NO996265L - Behandling av diabetes med rosiglitazon og insulin - Google Patents
Behandling av diabetes med rosiglitazon og insulinInfo
- Publication number
- NO996265L NO996265L NO996265A NO996265A NO996265L NO 996265 L NO996265 L NO 996265L NO 996265 A NO996265 A NO 996265A NO 996265 A NO996265 A NO 996265A NO 996265 L NO996265 L NO 996265L
- Authority
- NO
- Norway
- Prior art keywords
- rosiglitazone
- insulin
- diabetes
- treatment
- Prior art date
Links
- YASAKCUCGLMORW-UHFFFAOYSA-N Rosiglitazone Chemical compound C=1C=CC=NC=1N(C)CCOC(C=C1)=CC=C1CC1SC(=O)NC1=O YASAKCUCGLMORW-UHFFFAOYSA-N 0.000 title 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
- 229960004586 rosiglitazone Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9712866.4A GB9712866D0 (en) | 1997-06-18 | 1997-06-18 | Novel method of treatment |
| PCT/EP1998/003692 WO1998057636A1 (en) | 1997-06-18 | 1998-06-15 | Treatment of diabetes with rosiglitazone and insulin |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO996265D0 NO996265D0 (no) | 1999-12-17 |
| NO996265L true NO996265L (no) | 1999-12-17 |
Family
ID=10814527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO996265A NO996265L (no) | 1997-06-18 | 1999-12-17 | Behandling av diabetes med rosiglitazon og insulin |
Country Status (30)
| Country | Link |
|---|---|
| EP (1) | EP0999837A1 (enExample) |
| JP (1) | JP2002504138A (enExample) |
| KR (1) | KR20010013843A (enExample) |
| CN (1) | CN1133431C (enExample) |
| AP (1) | AP1287A (enExample) |
| AR (2) | AR012997A1 (enExample) |
| AU (1) | AU8216398A (enExample) |
| BG (1) | BG104059A (enExample) |
| BR (1) | BR9810444A (enExample) |
| CA (1) | CA2294141A1 (enExample) |
| CO (1) | CO4940454A1 (enExample) |
| DZ (1) | DZ2521A1 (enExample) |
| EA (1) | EA004800B1 (enExample) |
| GB (1) | GB9712866D0 (enExample) |
| HU (1) | HUP0003260A3 (enExample) |
| ID (1) | ID23951A (enExample) |
| IL (1) | IL133143A0 (enExample) |
| IN (1) | IN189723B (enExample) |
| MA (1) | MA26511A1 (enExample) |
| NO (1) | NO996265L (enExample) |
| OA (1) | OA11517A (enExample) |
| PE (1) | PE104499A1 (enExample) |
| PL (1) | PL343123A1 (enExample) |
| SK (1) | SK179399A3 (enExample) |
| TR (1) | TR199903095T2 (enExample) |
| TW (1) | TW587937B (enExample) |
| UA (1) | UA70299C2 (enExample) |
| UY (1) | UY25050A1 (enExample) |
| WO (1) | WO1998057636A1 (enExample) |
| ZA (1) | ZA985237B (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6291495B1 (en) * | 1997-02-24 | 2001-09-18 | Robert B. Rieveley | Method and composition for the treatment of diabetes |
| US7045519B2 (en) | 1998-06-19 | 2006-05-16 | Chiron Corporation | Inhibitors of glycogen synthase kinase 3 |
| TWI249401B (en) | 1999-04-14 | 2006-02-21 | Takeda Chemical Industries Ltd | Agent for improving ketosis |
| HRP20010773B1 (en) | 1999-04-23 | 2005-06-30 | Smithkline Beecham P.L.C. | Thiazolidinedione derivative and its use as antidiabetic |
| SI1133312T1 (sl) * | 1999-06-21 | 2008-02-29 | Lilly Co Eli | Uporaba tiazolidindionov v kombinaciji z glukagonu podobnim peptidom-1 in njegovimi agonisti za zdravljenje sladkorne bolezni, neodvisne od inzulina |
| EP1196189A2 (en) | 1999-06-25 | 2002-04-17 | Medtronic MiniMed, Inc. | Multiple agent diabetes therapy |
| US6468507B1 (en) * | 2000-05-01 | 2002-10-22 | Aeropharm Technology, Inc. | Non-aqueous aerosol formulation comprising rosiglitazone maleate, a non-aqueous carrier, and an amino acid stabilizer |
| GB0023970D0 (en) * | 2000-09-29 | 2000-11-15 | Smithkline Beecham Plc | Novel pharmaceutical |
| WO2002067969A2 (en) | 2001-02-21 | 2002-09-06 | Medtronic Minimed, Inc. | Stabilized insulin formulations |
| US6531461B1 (en) | 2001-06-04 | 2003-03-11 | Louis Obyo Obyo Nelson | Medicament for the treatment of diabetes |
| WO2002100396A1 (en) * | 2001-06-07 | 2002-12-19 | Wyeth | COMBINATION OF A PTPase INHIBITOR AND A THIAZOLIDINEDIONE AGENT |
| US6737401B2 (en) | 2001-06-28 | 2004-05-18 | Metronic Minimed, Inc. | Methods of evaluating protein formulation stability and surfactant-stabilized insulin formulations derived therefrom |
| CA2503117C (en) | 2002-11-08 | 2010-12-21 | F. Hoffmann-La Roche Ag | Substituted 4-alkoxyoxazol derivatives as ppar agonists |
| US7264813B2 (en) | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
| CN102389427A (zh) * | 2011-10-10 | 2012-03-28 | 成都恒瑞制药有限公司 | 含有罗格列酮和盐酸西替利嗪的固体口服制剂 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1103590C (zh) * | 1993-09-15 | 2003-03-26 | 三共株式会社 | 使用噻唑烷二酮防止或延缓非胰岛素依赖性糖尿病(niddm)的发作 |
| JPH11510508A (ja) * | 1995-08-10 | 1999-09-14 | ワーナー−ランバート・コンパニー | インシュリン非依存性真性糖尿病患者に投与される外来インシュリンの量を減らす方法 |
| PT859608E (pt) * | 1995-09-18 | 2004-06-30 | Ligand Pharm Inc | Tratamento de niddm com agonistas de rxr |
-
1997
- 1997-06-18 GB GBGB9712866.4A patent/GB9712866D0/en active Pending
-
1998
- 1998-06-15 UA UA99126881A patent/UA70299C2/uk unknown
- 1998-06-15 EA EA200000042A patent/EA004800B1/ru not_active IP Right Cessation
- 1998-06-15 HU HU0003260A patent/HUP0003260A3/hu unknown
- 1998-06-15 IL IL13314398A patent/IL133143A0/xx unknown
- 1998-06-15 PL PL98343123A patent/PL343123A1/xx unknown
- 1998-06-15 AU AU82163/98A patent/AU8216398A/en not_active Abandoned
- 1998-06-15 AP APAP/P/1999/001718A patent/AP1287A/en active
- 1998-06-15 CN CNB988062232A patent/CN1133431C/zh not_active Expired - Fee Related
- 1998-06-15 BR BR9810444-6A patent/BR9810444A/pt not_active IP Right Cessation
- 1998-06-15 TR TR1999/03095T patent/TR199903095T2/xx unknown
- 1998-06-15 CA CA002294141A patent/CA2294141A1/en not_active Abandoned
- 1998-06-15 JP JP50375799A patent/JP2002504138A/ja not_active Ceased
- 1998-06-15 WO PCT/EP1998/003692 patent/WO1998057636A1/en not_active Ceased
- 1998-06-15 KR KR1019997011864A patent/KR20010013843A/ko not_active Ceased
- 1998-06-15 ID IDW991627A patent/ID23951A/id unknown
- 1998-06-15 SK SK1793-99A patent/SK179399A3/sk unknown
- 1998-06-15 EP EP98932169A patent/EP0999837A1/en not_active Withdrawn
- 1998-06-17 ZA ZA9805237A patent/ZA985237B/xx unknown
- 1998-06-17 DZ DZ980131A patent/DZ2521A1/xx active
- 1998-06-17 AR ARP980102883A patent/AR012997A1/es not_active Application Discontinuation
- 1998-06-17 MA MA25122A patent/MA26511A1/fr unknown
- 1998-06-17 AR ARP980102886A patent/AR015894A1/es not_active Application Discontinuation
- 1998-06-17 TW TW087109619A patent/TW587937B/zh not_active IP Right Cessation
- 1998-06-18 IN IN1698DE1998 patent/IN189723B/en unknown
- 1998-06-18 UY UY25050A patent/UY25050A1/es unknown
- 1998-06-18 CO CO98034654A patent/CO4940454A1/es unknown
- 1998-06-18 PE PE1998000535A patent/PE104499A1/es not_active Application Discontinuation
-
1999
- 1999-12-17 NO NO996265A patent/NO996265L/no not_active Application Discontinuation
- 1999-12-17 OA OA9900296A patent/OA11517A/en unknown
-
2000
- 2000-01-06 BG BG104059A patent/BG104059A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PL343123A1 (en) | 2001-07-30 |
| NO996265D0 (no) | 1999-12-17 |
| AR015894A1 (es) | 2001-05-30 |
| PE104499A1 (es) | 2000-01-13 |
| EA004800B1 (ru) | 2004-08-26 |
| SK179399A3 (en) | 2000-11-07 |
| TW587937B (en) | 2004-05-21 |
| DZ2521A1 (fr) | 2003-02-08 |
| HUP0003260A3 (en) | 2001-12-28 |
| HUP0003260A2 (hu) | 2001-05-28 |
| CN1133431C (zh) | 2004-01-07 |
| WO1998057636A1 (en) | 1998-12-23 |
| CA2294141A1 (en) | 1998-12-23 |
| IL133143A0 (en) | 2001-03-19 |
| ID23951A (id) | 2000-06-08 |
| CN1260715A (zh) | 2000-07-19 |
| KR20010013843A (ko) | 2001-02-26 |
| AR012997A1 (es) | 2000-11-22 |
| TR199903095T2 (xx) | 2000-08-21 |
| BG104059A (en) | 2000-10-31 |
| OA11517A (en) | 2004-02-04 |
| AU8216398A (en) | 1999-01-04 |
| AP1287A (en) | 2004-06-26 |
| AP9901718A0 (en) | 1999-12-31 |
| IN189723B (enExample) | 2003-04-19 |
| MA26511A1 (fr) | 2004-12-20 |
| JP2002504138A (ja) | 2002-02-05 |
| EA200000042A1 (ru) | 2000-08-28 |
| BR9810444A (pt) | 2000-09-05 |
| UY25050A1 (es) | 2000-09-29 |
| ZA985237B (en) | 2000-02-17 |
| CO4940454A1 (es) | 2000-07-24 |
| EP0999837A1 (en) | 2000-05-17 |
| GB9712866D0 (en) | 1997-08-20 |
| UA70299C2 (en) | 2004-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP9901719A0 (en) | Treatment of diabetes with thiazolidinedione and metormin | |
| NO970373D0 (no) | Benzoksazoler og pyridinderivater anvendelige ved behandling av type-II-diabetes | |
| NO996265D0 (no) | Behandling av diabetes med rosiglitazon og insulin | |
| NO996205D0 (no) | Behandling av insulinresistens med veksthormonutskillelsesmiddel | |
| NO20000228D0 (no) | Behandling av diabetes med tiazolidindion, insulin utskillende middel og diguanid | |
| NO20000230D0 (no) | Behandling av diabetes med tiazolidindion, insulin sekretagogue og <alfa>glukosidaseinhibitor | |
| NO20000229D0 (no) | Behandling av diabetes med tiazolidindion og sulfonylurea | |
| NO996264L (no) | Behandling av diabetes med tiazolidindion og sulfonylurea | |
| NO996270D0 (no) | Behandling av diabetes med tiazolidindion og <alfa>- glukosidaseinhibitor | |
| HK1028198A (en) | Treatment of diabetes with rosiglitazone and insulin | |
| HUP0002668A3 (en) | Treatment of diabetes with thiazolidinedione and metformin | |
| HUP0002669A3 (en) | Treatment of diabetes with thiazolidinedione and sulphonylurea | |
| HK1025263A (en) | Treatment of diabetes with thiazolidinedione and alpha-glucosidase inhibitor | |
| DK398089D0 (da) | Peptider og laegemidler mod demens med indhold af saadanne forbindelser |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |